Allergan resists $47B offer by swallowing poison pill April 23, 2014 By Arezu Sarvestani Leave a Comment Aesthetics products maker Allergan (NYSE:AGN) last night adopted a "poison pill" strategy designed to insulate the company from a surprise $47 billion hostile takeover.